ADA Scientific Sessions 2025 Abstract

The First Real-World Experience of the Effectiveness and Safety of Tirzepatide in Improving Metabolic Parameters in Type 2 Diabetes—A Six-Month Observational Study from India

By Purvi M. Chawla, Manoj S Chawla, Anam Shaikh, Shatavisa Mukherjee

Study in peopleInterventions

The paper

Purvi M. Chawla, Manoj S Chawla, Anam Shaikh, Shatavisa Mukherjee

Mumbai

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 784-P

doi.org/10.2337/db25-784-p

Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety